Detalles de la búsqueda
1.
Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1.
Leukemia
; 34(7): 1970, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31937894
2.
Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1.
Leukemia
; 33(8): 1910-1922, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30858550
3.
Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale.
Leukemia
; 30(9): 1844-52, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27109508
4.
Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors.
Leukemia
; 23(5): 919-24, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19148139
5.
Molecular evidence for repertoire skewing of T large granular lymphocyte proliferation after allogeneic hematopoietic SCT: report of two cases.
Bone Marrow Transplant
; 48(9): 1260-1, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23604008
Resultados
1 -
5
de 5
1
Próxima >
>>